Less Ads, More Data, More Tools Register for FREE

Pin to quick picksRWS Holdings Regulatory News (RWS)

Share Price Information for RWS Holdings (RWS)

Share Price is delayed by 15 minutes
Get Live Data
103.00    -1.50 (-1.44%)
Bid:
102.50
Ask:
102.80
Spread: 0.30 (0.293%)
Market Cap: £382.30m
RWS Live PriceLast checked at - London Stock Exchange

Intraday RWS Holdings Share Chart

Form 8.5 (EPT/RI)

15 Oct 2020 13:19

RNS Number : 2384C
Nplus1 Singer Capital Markets Ltd
15 October 2020
 

 

FORM 8.5 (EPT/RI)

 

PUBLIC DEALING DISCLOSURE BY AN EXEMPT PRINCIPAL TRADER WITH RECOGNISED INTERMEDIARY STATUS DEALING IN A CLIENT-SERVING CAPACITY

Rule 8.5 of the Takeover Code (the "Code")

 

1. KEY INFORMATION

 

(a) Name of exempt principal trader:

Nplus1 Singer Capital Markets Limited

 

(b) Name of offeror/offeree in relation to whose relevant securities this form relates:

Use a separate form for each offeror/offeree

RWS Holdings Plc

(c) Name of the party to the offer with which exempt principal trader is connected:

SDL Plc

(d) Date dealing undertaken:

14 October 2020

(e) In addition to the company in 1(b) above, is the exempt principal trader making disclosures in respect of any other party to this offer?

If it is a cash offer or possible cash offer, state "N/A"

YES

 

If YES, specify which: SDL PLC

 

2. DEALINGS BY THE EXEMPT PRINCIPAL TRADER

 

Where there have been dealings in more than one class of relevant securities of the offeror or offeree named in 1(b), copy table 2(a), (b), (c) or (d) (as appropriate) for each additional class of relevant security dealt in.

 

The currency of all prices and other monetary amounts should be stated.

 

(a) Purchases and sales

 

Class of relevant security

Purchases/ sales

 

Total number of securities

Highest price per unit paid/received

Lowest price per unit paid/received

 

ORD1P

 

 

Sale

 

3,230

 

620.98p

 

625.98p

 

(b) Cash-settled derivative transactions

 

Class of relevant security

Product description

e.g. CFD

Nature of dealing

e.g. opening/closing a long/short position, increasing/reducing a long/short position

Number of reference securities

Price per unit

 

 

 

(c) Stock-settled derivative transactions (including options)

 

(i) Writing, selling, purchasing or varying

 

Class of relevant security

Product description e.g. call option

Writing, purchasing, selling, varying etc.

Number of securities to which option relates

Exercise price per unit

Type

e.g. American, European etc.

Expiry date

Option money paid/ received per unit

 

(ii) Exercise

 

Class of relevant security

Product description

e.g. call option

Exercising/ exercised against

Number of securities

Exercise price per unit

 

 

 

(d) Other dealings (including subscribing for new securities)

 

Class of relevant security

Nature of dealing

e.g. subscription, conversion

Details

Price per unit (if applicable)

 

 

 

3. OTHER INFORMATION

 

(a) Indemnity and other dealing arrangements

 

Details of any indemnity or option arrangement, or any agreement or understanding, formal or informal, relating to relevant securities which may be an inducement to deal or refrain from dealing entered into by the exempt principal trader making the disclosure and any party to the offer or any person acting in concert with a party to the offer:

Irrevocable commitments and letters of intent should not be included. If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

(b) Agreements, arrangements or understandings relating to options or derivatives

 

Details of any agreement, arrangement or understanding, formal or informal, between the exempt principal trader making the disclosure and any other person relating to:

(i) the voting rights of any relevant securities under any option; or

(ii) the voting rights or future acquisition or disposal of any relevant securities to which any derivative is referenced:

If there are no such agreements, arrangements or understandings, state "none"

 

 

 

 

Date of disclosure:

15 October 2020

Contact name:

Sarah-Rose Perry, Jennifer Bentick

Telephone number:

020 7496 3093

 

Public disclosures under Rule 8 of the Code must be made to a Regulatory Information Service and must also be emailed to the Takeover Panel at monitoring@disclosure.org.uk. The Panel's Market Surveillance Unit is available for consultation in relation to the Code's dealing disclosure requirements on +44 (0)20 7638 0129.

 

The Code can be viewed on the Panel's website at www.thetakeoverpanel.org.uk.

This information is provided by RNS, the news service of the London Stock Exchange. RNS is approved by the Financial Conduct Authority to act as a Primary Information Provider in the United Kingdom. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact rns@lseg.com or visit www.rns.com.RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our Privacy Policy.
 
END
 
 
FERMZMMGZKKGGZM
Date   Source Headline
2nd Jun 202610:17 amRNSHolding(s) in Company
1st Jun 20267:00 amRNSTotal Voting Rights
5th May 202612:23 pmRNSUpdate re Agreement to acquire Obviously Group Ltd
5th May 20267:00 amRNSAgreement in principle to acquire Obviously Group
1st May 20267:00 amRNSTotal Voting Rights
28th Apr 202612:10 pmRNSHolding(s) in Company
27th Apr 20262:48 pmRNSHolding(s) in Company
23rd Apr 20267:00 amRNSTrading Statement
1st Apr 20267:00 amRNSTotal Voting Rights
26th Mar 20263:41 pmRNSDirector/PDMR Shareholding
25th Mar 20269:15 amRNS-RRWS launches Language Weaver Pro
25th Mar 20267:00 amRNSIssue of Equity and Total Voting Rights
10th Mar 20264:40 pmRNSHolding(s) in Company
10th Mar 20264:40 pmRNSHolding(s) in Company
4th Mar 20269:37 amRNSDirector/PDMR Shareholding
2nd Mar 20267:00 amRNSTotal Voting Rights
12th Feb 202611:45 amRNSDirector/PDMR Shareholding
11th Feb 202611:44 amRNSResult of AGM
11th Feb 20267:00 amRNSAGM Statement
10th Feb 20262:00 pmRNSHolding(s) in Company
6th Feb 202612:30 pmRNSDirector/PDMR Shareholding
2nd Feb 20267:00 amRNSTotal Voting Rights
30th Jan 20263:06 pmRNSHolding(s) in Company
28th Jan 20263:24 pmRNSDirector/PDMR Shareholding
28th Jan 20263:19 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20261:00 pmRNSDirector/PDMR Shareholding
23rd Jan 20269:00 amRNSOption Exercise, Admission and Total Voting Rights
23rd Jan 20267:00 amRNSHolding(s) in Company
14th Jan 20267:00 amRNSHolding(s) in Company
8th Jan 20269:00 amRNSPublication of Annual Report and Notice of AGM
2nd Jan 20264:51 pmRNSHolding(s) in Company
2nd Jan 20267:00 amRNSTotal Voting Rights
2nd Jan 20267:00 amRNSTotal Voting Rights
19th Dec 20257:00 amRNSHolding(s) in Company
19th Dec 20257:00 amRNSHolding(s) in Company
12th Dec 20253:53 pmRNSHolding(s) in Company
11th Dec 20257:01 amRNSDirectorate change
11th Dec 20257:00 amRNSFinal Results
1st Dec 20257:00 amRNSTotal Voting Rights
11th Nov 20258:00 amRNSHolding(s) in Company
7th Nov 20259:00 amRNSHolding(s) in Company
3rd Nov 20257:00 amRNSTotal Voting Rights
31st Oct 20259:00 amRNSHolding(s) in Company
28th Oct 20257:00 amRNSTrading Statement
20th Oct 20253:06 pmRNSHolding(s) in Company
20th Oct 20259:05 amRNS-RHead of Media & Entertainment appointment
15th Oct 20257:00 amRNSDirectorate Change
3rd Oct 20257:00 amRNSDirectorate Change
2nd Oct 202511:38 amRNSHolding(s) in Company

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.